VIDEO: CohBar, Inc. CEO Simon Allen Interviewed for OTCQX Video Series

Press Releases  |

NEW YORK, Aug. 29, 2016 /PRNewswire/ -- Simon Allen, CohBar, Inc. CEO was interviewed by the OTC Markets Group (OTCQX: OTCM) for its OTCQX® Video Series. The series features one-on-one interviews with senior executives of OTCQX companies as they showcase their businesses and investment profiles.

In the interview, Simon Allen discusses:

  • How CohBar's development of mitochondria-based therapeutics may lead to novel treatments for age related diseases, such as diabetes, obesity, cancer, Alzheimer's and cardiovascular disease;
  • The company's semi-virtual business which enables CohBar to focus on maintaining expertise in key areas, while other functions, such as manufacturing, clinical and regulatory are outsourced to experienced third party providers and
  • How trading on our OTCQX Best Market provides CohBar with important access to investors in the U.S. capital markets.

To watch the complete interview, visit OTC Markets Group's YouTube page at

About CohBar

CohBar (OTCQX: CWBR) is a leader in the research and development of mitochondria-based therapeutics (MBTs), an emerging class of drugs for the treatment of diseases associated with aging. MBTs originate from the discovery of a novel group of peptides within the genome of mitochondria, the powerhouses of the cell. This groundbreaking discovery was made by our founders, world leaders in the biology of aging, metabolism and mitochondrial genomics. MBTs offer the potential to address a broad range of diseases such as type 2 diabetes, cancer, atherosclerosis and neurodegenerative disorders.

About OTC Markets Group Inc.
OTC Markets Group Inc. (OTCQX: OTCM) operates the OTCQX® Best Market, the OTCQB® Venture Market, and the Pink® Open Market for 10,000 U.S. and global securities. Through OTC Link® ATS, we connect a diverse network of broker-dealers that provide liquidity and execution services. We enable investors to easily trade through the broker of their choice and empower companies to improve the quality of information available for investors.

To learn more about how we create better informed and more efficient markets, visit

OTC Link ATS is operated by OTC Link LLC, member FINRA/SIPC and SEC regulated ATS.

Subscribe to the OTC Markets RSS Feed

The information contained in this press release and in the video to which it refers is provided "as is" for educational and informational purposes only, and should not serve as the basis for any trading or investing decisions. OTC Markets Group makes no representations and disclaims all express, implied and statutory warranties of any kind to any viewer or third party. Neither OTC Markets Group nor any of its affiliates makes any endorsement of any particular company, security, product or financial strategy, and nothing contained in this video should be construed as investment advice. Investors should undertake their own diligence and carefully evaluate companies before investing.

Media Contact:
OTC Markets Group Inc., +1 (212) 896-4428,

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not necessarily represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Symbol Last Price Change % Change